Paradoxical stimulation of matrix metalloproteinase-9 expression in HT1080 cells by a broad-spectrum hydroxamate-based matrix metalloproteinase inhibitor.
Laboratoire de Biologie des Tumeurs et du Développement, Université de Liège, Belgium.
E
E
Maquoi
C
C
Munaut
A
A
Colige
C
C
Lambert
F
F
Frankenne
A
A
Noël
F
F
Grams
H W
HW
Krell
J M
JM
Foidart
D003094:Collagen; D017364:Collagenases / Q000096:biosynthesis / Q000235:genetics*; D005354:Fibrosarcoma; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects*; D017930:Genes, Reporter; D006801:Humans; D006877:Hydroxamic Acids / Q000494:pharmacology; D020780:Matrix Metalloproteinase 9; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors*; D009361:Neoplasm Invasiveness; D010649:Phenylalanine / Q000031:analogs & derivatives* / Q000494:pharmacology; D011401:Promoter Regions, Genetic; D011480:Protease Inhibitors / Q000494:pharmacology*; D014158:Transcription, Genetic / Q000187:drug effects; D014407:Tumor Cells, Cultured
D006877:Hydroxamic Acids; D011480:Protease Inhibitors; C088672:GI 129471; D010649:Phenylalanine; D003094:Collagen; D017364:Collagenases; D008666:Metalloendopeptidases; D020780:Matrix Metalloproteinase 9